Gut Microbiota Metabolites As A New Therapeutic Target In Patients With Coronary Artery Disease And Atrial Fibrillation. Journal of Pharmaceutical Negative Results, [S. l.], p. 1221–1227, 2023. DOI: 10.47750/pnr.2023.14.02.157. Disponível em: https://pnrjournal.com/index.php/home/article/view/7523.. Acesso em: 8 jun. 2026.